Randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder-Reference-Cited by-同舟云学术

Randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder

Published:2017-10-03 Issue:2 Volume:72 Page:64-72
ISSN:1323-1316
Container-title:Psychiatry and Clinical Neurosciences
language:en
Short-container-title:Psychiatry Clin. Neurosci.

Author:

Nishimura Akira¹^ORCID,Aritomi Yutaka¹,Sasai Kiyofumi¹,Kitagawa Tadayuki¹,Mahableshwarkar Atul R.²

Affiliation:

1. Takeda Pharmaceutical Company Limited; Osaka Japan

2. Takeda Development Center Americas, Inc.; Deerfield USA

Funder

H. Lundbeck A/S

Takeda Pharmaceuticals U.S.A.

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology,Neurology,General Medicine,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcn.12565/fullpdf

Reference34 articles.

1. World Health Organization http://www.who.int/mediacentre/factsheets/fs369/en/

2. Diagnostic and Statistical Manual of Mental Disorders

3. A systematic review of antidepressant placebo-controlled trials for geriatric depression: Limitations of current data and directions for the future;Taylor;Neuropsychopharmacology,2004

4. Medication augmentation after the failure of SSRIs for depression;Trivedi;N. Engl. J. Med.,2006

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The dose-response relationship of vortioxetine on major depressive disorder: an umbrella review;Psychiatry Research;2024-10

2. Vortioxetine for depression in adults: A systematic review and dose–response meta‐analysis of randomized controlled trials;Psychiatry and Clinical Neurosciences;2024-07-03

3. Feasibility of remote interviews in assessing disease severity in patients with major depressive disorder: A pilot study;Neuropsychopharmacology Reports;2024-01-24

4. The Role of Vortioxetine in the Treatment of Depressive Symptoms in General Hospital Psychiatry: A Case-Series and PRISMA-Compliant Systematic Review of the Literature;Journal of Clinical Medicine;2024-01-17

5. Clinical outcomes of deep brain stimulation for obsessive‐compulsive disorder: Insight as a predictor of symptom changes;Psychiatry and Clinical Neurosciences;2023-12-05